Results 221 to 230 of about 87,208 (292)

Photobiomodulation and Radio‐Epithelitis in Anal Carcinoma: A Case‐Report and Clinical Reflection on Emerging Preventive and Supportive Care Modalities

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Radio‐induced dermatitis, a frequent adverse effect of radiation therapy, is particularly prevalent in patients treated for anal margin carcinoma. It may present with varying severity, causing significant pain and impairment of daily mobility, influenced by both patient‐related factors and treatment regimens.
Michèle Pelletier‐Aouizerate, Yvona Zivic   +1 more
wiley   +1 more source

Technical Approach to Repair of Tracheogastric Conduit Fistula Following Minimally Invasive Esophagectomy: A Case Report. [PDF]

Am J Case Rep
Chaochankit W, Samphao S, Chittithavorn V, Sungworawongpana C.   +3 more
europepmc   +1 more source

DWI for Assessment of Rectal Cancer Nodes After Chemoradiotherapy: Is the Absence of Nodes at DWI Proof of a Negative Nodal Status?

, 2016
Miriam M. van Heeswijk, Doenja M. J. Lambregts, Walter M. Palm, Babs M.F. Hendriks, Monique Maas, Geerard L. Beets, Regina G. H. Beets‐Tan   +6 more
openalex   +2 more sources

Minimal residual disease in solid tumors: Clinical applications and future directions

Cancer, Volume 132, Issue 3, 1 February 2026.
Abstract Minimal residual disease (MRD) refers to the presence of residual cancer cells or tumor‐derived fragments that persist after treatment and remain undetectable by conventional imaging or protein‐based assays. Circulating tumor DNA (ctDNA) has emerged as a dynamic biomarker for MRD detection.
Theresa Abdo, Ahmad Alhalabi, Sacha Yaghi, Mohammad Aloran, You Li, María Herrán, Rami Tfayli, Thomas A. Samuel, Zeina Nahleh   +8 more
wiley   +1 more source

Time Factor and the Role of Gastrostomy Tube Placement in the Treatment of Advanced Head and Neck Tumors

Acta Medica Martiniana, 2011
Hajtmanova E., Hajtman A., Pec M., Kinclova I., Murin P., Hajtman A.   +5 more
doaj   +1 more source

Updated protocol of the POINT trial: a multicenter randomized controlled trial investigating effects of preoperative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy. [PDF]

Trials
Cheng Y, Cao Y, Zhao S, Jin Q, Li J, Li C, Zhang Y, Shen W, He J, Wang M, Ji G, Li Z, He Y, Chen Q, Wei W, Tan L, Wang H, Shi Y, Li H.   +18 more
europepmc   +1 more source

G-CSF-producing pulmonary sarcomatoid carcinoma treated with chemoradiotherapy followed by durvalumab: a case report. [PDF]

Respir Med Case Rep
Hashimoto N, Kaira K, Uno T, Hashimoto K, Mouri A, Yamaguchi O, Imai H, Shojiguchi N, Homma T, Kagamu H.   +9 more
europepmc   +1 more source

Single‐cell sequencing for cancer precision medicine: From mechanism discovery to diagnosis and therapeutics

Clinical and Translational Discovery, Volume 6, Issue 1, February 2026.
Single‐cell sequencing overcomes bulk sequencing limitations, enabling high‐resolution multi‐omics analysis at the single‐cell level. It reveals tumour heterogeneity, identifying key subpopulations and tumour microenvironment interactions driving progression and resistance.
Yue Zhao, Hancong Li, Huanzuo Yang, Gongshuang Zhang, Xinyue Fu, Peiheng Li, Puxing He, Shuang Wu, Han Luo   +8 more
wiley   +1 more source

Impact of KRAS G12C mutation on the efficacy of chemoradiotherapy in patients with unresectable stage II or III non-small cell lung cancer. [PDF]

Front Oncol
Cabon J, Lerouge D, Thureau S, Balosso J, Guigo M, Gervais R, Dubos C, Dô P, Demontrond P, Curcio H, Deshayes S, Madelaine J, Leite Ferreira D, Jacson L, Lecrosnier K, Chevalier F, Guisier F, Dantoing E, Leconte A, Christy F, Césaire M.   +20 more
europepmc   +1 more source